673456-34-3

Upstream product

• 341536-45-6 9-[2-O-acetyl-5-O-benzoyl-4-C-[(benzoyloxy)methyl]-3-O-benzyl-α-L-threo-pentofuranosyl]-6-N-benzoyladenine 
• 4005-49-6 N-benzoyladenine 
• 230631-16-0 1,2-Di-O-acetyl-5-O-benzoyl-4-C-benzoyloxymethyl-3-O-benzyl-L-threo-pentofuranose 

Downstream Products

• 673456-35-4 C₃₈H₄₃N₅O₇Si 
• 206055-79-0 (1S,3R,4S,7R)-7-[2-cyanoethoxy(diisopropylamino)phosphinoxy]-1-[[(4,4'-dimethoxytrityl)oxy]methyl]-3-(6-N-benzoyladenin-9-yl)-2,5-dioxabicyclo[2.2.1]heptane 
• 341536-46-7 9-[2-O-acetyl-5-O-benzoyl-4-C-[(benzoyloxy)methyl]-3-O-benzyl-α-L-erythro-pentofuranosyl]-6-N-benzoyladenine 
• 341536-51-4 (1S,3R,4S,7R)-1-[[(4,4'-dimethoxytrityl)oxy]methyl]-7-hydroxy-3-(6-N-benzoyladenin-9-yl)-2,5-dioxabicyclo[2.2.1]heptane 
• 341536-48-9 9-[3-O-benzyl-5-O-(methanesulfonyl)-4-C-[[(methanesulfonyl)oxy]methyl]-α-L-erythro-pentofuranosyl]-6-N-benzoyladenine 
• 410076-88-9 (1S,3R,4S,7R)-1-(acetoxymethyl)-3-(6-N-benzoyladenin-9-yl)-7-benzyloxy-2,5-dioxabicyclo[2.2.1]heptane 
• 625111-39-9 (1S,3R,4S,7R)-7-benzyloxy-3-(6-N-benzoyladenin-9-yl)-2,5-dioxabicyclo[2.2.1]heptane 
• 341536-47-8 9-[3-O-benzyl-4-C-(hydroxymethyl)-α-L-erythro-pentofuranosyl]-6-N-benzoyladenine 
• 303183-65-5 (1R,3R,4S,7R)-3-(6-N-benzoyladenin-9-yl)-7-benzyloxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptane 
• 341536-49-0 (1R,3R,4S,7R)-3-(6-N-benzoyladenin-9-yl)-7-hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptane 
• 673456-37-6 Methanesulfonic acid (3R,4R,5R)-5-(6-benzoylamino-purin-9-yl)-3-benzyloxy-4-(tert-butyl-dimethyl-silanyloxy)-2-methanesulfonyloxymethyl-tetrahydro-furan-2-ylmethyl ester 
• 673456-38-7 Methanesulfonic acid (1R,3R,4R,7R)-3-(6-benzoylamino-purin-9-yl)-7-benzyloxy-2,5-dioxa-bicyclo[2.2.1]hept-1-ylmethyl ester 
• 673456-36-5 [(3R,4R,5R)-5-(6-Amino-purin-9-yl)-3-benzyloxy-4-(tert-butyl-dimethyl-silanyloxy)-2-hydroxymethyl-tetrahydro-furan-2-yl]-methanol 
• 673456-39-8 (1S,3R,4R,7R)-7-benzyloxy-1-hydroxymethyl-3-(adenin-9-yl)-2,5-dioxabicyclo[2.2.1]heptane 

Relevant academic research and scientific papers

&α-L-ribo-Configured Locked Nucleic Acid (&α-L-LNA): Synthesis and Properties

The syntheses of monomeric nucleosides and 3'-O-phosphoramidite building blocks en route to α-L-ribo-configured locked nucleic acids (α-L-LNA), composed entirely of α-L-LNA monomers (α-L-ribo configuration) or of a mixture of α-L-LNA and DNA monomers (β-D

Synthesis of a base-protected xylo-LNA adenine nucleoside

Synthesis of (1S,3R,4R,7R)-7-hydroxy-1-hydroxymethyl-3-(6-N-benzoyl-adenin-9-yl)-2, 5-dioxabicyclo[2.2.1]heptane (2), a base-protected xylo-LNA adenine nucleoside, has been accomplished using a convergent synthetic strategy starting from 1,2-di-O-acetylfu

The adenine derivative of α-L-LNA (α-L-ribo configured locked nucleic acid): Synthesis and high-affinity hybridization towards DNA, RNA, LNA and α-L-LNA complementary sequences

Synthesis of a 9-mer α-L-LNA (α-L-ribo configured locked nucleic acid) containing three 9-(2-O,4-C-methylene-α-L-ribofuranosyl)adenine nucleotide monomer(s) has been accomplished. The work involved synthesis of the bicyclic adenine nucleoside via a conden